DSM-Firmenich AG (MEX:DSFIR N) EBIT: MXN15,826 Mil (TTM As of Dec. 2025)


MEX:DSFIR N DSM-Firmenich AG MEX:DSFIR N
51 GF Score
Price MXN1,301.79
GF Value MXN1,302.81
! 5 Warning Signs
View Full Analysis

What is DSM-Firmenich AG EBIT?

DSM-Firmenich AG MEX:DSFIR N 51 EBIT is MXN15,826 Mil as of Dec. 2025. GuruFocus rates MEX:DSFIR N with a GF Score™ of 51/100 and a GF Value™ of MXN1,302.81. The stock has 5 warning signs investors should review.

DSM-Firmenich AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was MXN-1,244 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was MXN15,826 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. DSM-Firmenich AG's annualized ROC % for the quarter that ended in Dec. 2025 was -1.12%. DSM-Firmenich AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was -1.48%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 3.55%.

DSM-Firmenich AG  (MEX:DSFIR N) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

DSM-Firmenich AG's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=-6493.86 * ( 1 - 2.78% )/( (587722.964 + 538800.543)/ 2 )
=-6313.330692/563261.7535
=-1.12 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=701914.353 - 52078.918 - ( 62112.471 - max(0, 74230.918 - 200019.529+62112.471))
=587722.964

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=618708.743 - 39785.428 - ( 40122.772 - max(0, 117922.576 - 187499.637+40122.772))
=538800.543

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

DSM-Firmenich AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-2487.908/( ( (120055.153 + max(66173.669, 0)) + (88004.44 + max(62998.866, 0)) )/ 2 )
=-2487.908/( ( 186228.822 + 151003.306 )/ 2 )
=-2487.908/168616.064
=-1.48 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(60157.882 + 70625.788 + 4191.505) - (52078.918 + 0 + 16722.588)
=66173.669

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(38815.566 + 44719.075 + 62387.431) - (39785.428 + 0 + 43137.778)
=62998.866

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

DSM-Firmenich AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=15826.117/445617.855
=3.55 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG EBIT Related Terms

DSM-Firmenich AG EBIT Historical Data

* Premium members only.

The historical data trend for DSM-Firmenich AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DSM-Firmenich AG EBIT Chart

DSM-Firmenich AG Annual Data
Trend Dec21 Dec23 Dec24 Dec25
EBIT
19,911.33 -8,866.59 12,841.00 15,328.04

DSM-Firmenich AG Semi-Annual Data
Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EBIT Get a 7-Day Free Trial -1,999.15 3,096.08 9,412.36 17,070.07 -1,243.95

MEX:DSFIR N vs LIN, SHW, ECL: EBIT Comparison

For the Specialty Chemicals subindustry, DSM-Firmenich AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DSM-Firmenich AG EV-to-EBIT vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where DSM-Firmenich AG's EV-to-EBIT falls into.


MEX:DSFIR N
51GF Score
DSM-Firmenich AG MEX:DSFIR N
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DSM-Firmenich AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN15,826 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN15,826 Mil mean?
DSM-Firmenich AG (MEX:DSFIR N) has a EBIT of MXN15,826 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on DSM-Firmenich AG.
Is DSM-Firmenich AG's EBIT too high?
DSM-Firmenich AG's current EBIT is MXN15,826 Mil. Overall, DSM-Firmenich AG has a GF Score™ of 51/100, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EBIT compare to LIN and SHW?
DSM-Firmenich AG's EBIT of MXN15,826 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Chemicals company?
A good EBIT depends on the Chemicals industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on DSM-Firmenich AG. DSM-Firmenich AG's current EBIT is MXN15,826 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
DSM-Firmenich AG (MEX:DSFIR N) has a current EBIT of MXN15,826 Mil. The stock's GF Value™ is MXN1,302.81, compared to a current price of MXN1,301.79 — trading 0.1% below its estimated fair value. The current EBIT is MXN15,826 Mil. DSM-Firmenich AG's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For DSM-Firmenich AG (MEX:DSFIR N), the current EBIT is MXN15,826 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DSM-Firmenich AG (MEX:DSFIR N) Overvalued in 2026?

Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be undervalued. The current stock price of MXN1,301.79 is trading 0.1% below its estimated GF Value™ of MXN1,302.81.

Key valuation signals for MEX:DSFIR N:

  • EBIT: MXN15,826 Mil
  • GF Value™: MXN1,302.81 vs. price of MXN1,301.79 (0.1% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the MEX:DSFIR N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DSM-Firmenich AG Business Description

Address Wurmisweg 576, Kaiseraugst, CHE, 4303
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
51GF Score

Get the complete analysis for MEX:DSFIR N

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,301.79
Price
MXN1,302.81
GF Value